DSM-Firmenich (DSFIR) Stock Overview

Provides nutrition, health, and beauty solutions in Switzerland, the Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. More details

DSFIR fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	4/6
Past Performance	1/6
Financial Health	5/6
Dividends	2/6

Rewards

Trading at 35.6% below our estimate of its fair value

Earnings are forecast to grow 26.75% per year

Risk Analysis

Volatile share price over the past 3 months compared to the Swiss market

Dividend of 2.75% is not well covered by earnings

Profit margins (3.6%) are lower than last year (5.7%)

DSFIR Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW463,747 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.

Grow your followingReal investors. The kind who actually invest, not scroll past.

Unlock free accessFree premium subscription for consistent and quality authors.

Learn more Create Narrative

463,747 investors already sharing narratives

View all narratives

DSM-Firmenich AG Competitors

Price History & Performance

Summary of share price highs, lows and changes for DSM-Firmenich
Historical stock prices
Current Share Price	€84.60
52 Week High	€88.70
52 Week Low	€60.30
Beta	0.56
1 Month Change	6.42%
3 Month Change	28.77%
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	40.14%

Recent updates

Shareholder Returns

	DSFIR	CH Chemicals	CH Market
7D	0.3%	-2.1%	-1.1%
1Y	n/a	2.9%	14.7%

Return vs Industry: Insufficient data to determine how DSFIR performed against the Swiss Chemicals industry.

Return vs Market: Insufficient data to determine how DSFIR performed against the Swiss Market.

Price Volatility

Is DSFIR's price volatile compared to industry and market?
DSFIR volatility
DSFIR Average Weekly Movement	5.9%
Chemicals Industry Average Movement	4.9%
Market Average Movement	4.0%
10% most volatile stocks in CH Market	7.4%
10% least volatile stocks in CH Market	2.0%

Stable Share Price: DSFIR's share price has been volatile over the past 3 months compared to the Swiss market.

Volatility Over Time: Insufficient data to determine DSFIR's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1902	20,786	Dimitri de Vreeze	www.dsm-firmenich.com

DSM-Firmenich AG provides nutrition, health, and beauty solutions in Switzerland, the Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. The company operates through Perfumery & Beauty; Taste, Texture & Health; and Health, Nutrition & Care segments. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients.

DSM-Firmenich AG Fundamentals Summary

How do DSM-Firmenich's earnings and revenue compare to its market cap?
DSFIR fundamental statistics
Market cap	CHF 20.76b
Earnings (TTM)	CHF 302.97m
Revenue (TTM)	CHF 8.47b

69.2x

P/E Ratio

2.5x

P/S Ratio

Is DSFIR overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
DSFIR income statement (TTM)
Revenue	€9.06b
Cost of Revenue	€5.51b
Gross Profit	€3.55b
Other Expenses	€3.22b
Earnings	€324.00m

Last Reported Earnings

Jun 30, 2026

Next Earnings Date

Feb 18, 2027

Earnings per share (EPS)	1.31
Gross Margin	39.18%
Net Profit Margin	3.58%
Debt/Equity Ratio	37.6%

How did DSFIR perform over the long term?

See historical performance and comparison

Dividends

2.8%

Current Dividend Yield

195%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/08/21 19:34
End of Day Share Price	2026/08/21 00:00
Earnings	2026/06/30
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

DSM-Firmenich AG is covered by 44 analysts. 18 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Jennifer Barker	Barclays
Alexander Sloane	Barclays
Sebastian Bray	Berenberg

DSM-Firmenich AGSWX:DSFIR Stock Report